Patents by Inventor Judith DEL CAMPO ASCARATEIL

Judith DEL CAMPO ASCARATEIL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Influenza nucleoprotein vaccines
    Patent number: 9963490
    Abstract: The present invention is related to a fusion protein comprising a variant of a nucleoprotein antigen from Influenza strain A, B or C, and a variant of a C4bp oligomerization domain for increasing the cellular immunogenicity of the nucleoprotein antigen from Influenza. The invention is also related to nucleic acids, vectors, fusion proteins and immunogenic compositions, for their use as a vaccine or immunotherapy for the prevention and treatment of influenza disease.
    Type: Grant
    Filed: December 21, 2015
    Date of Patent: May 8, 2018
    Assignee: OSIVAX SAS
    Inventors: Judith Del Campo Ascarateil, Fergal Hill
  • Influenza Nucleoprotein Vaccines
    Publication number: 20160215032
    Abstract: The present invention is related to a fusion protein comprising a variant of a nucleoprotein antigen from Influenza strain A, B or C, and a variant of a C4bp oligomerization domain for increasing the cellular immunogenicity of the nucleoprotein antigen from Influenza. The invention is also related to nucleic acids, vectors, fusion proteins and immunogenic compositions, for their use as a vaccine or immunotherapy for the prevention and treatment of influenza disease.
    Type: Application
    Filed: December 21, 2015
    Publication date: July 28, 2016
    Inventors: Judith Del Campo Ascarateil, Fergal Hill
  • Modified coiled coil type proteins having improved properties
    Patent number: 9388225
    Abstract: The present application is related to a modified protein comprising a protein having a coiled coil domain and a peptide having the sequence such as shown in SEQ ID NO 1: ZXBBBBZ that is linked to the coiled coil domain wherein: Z is any amino acid or is absent; X is any amino acid; B is an arginine (R) or a lysine (K). Said modified protein is in particular an antigen or a carrier protein, associated to an antigen. This modified protein has an increased affinity for negatively charged polymers such as nucleic acids or heparin, and shows an increased immunogenicity.
    Type: Grant
    Filed: December 15, 2014
    Date of Patent: July 12, 2016
    Assignee: Imaxio
    Inventors: Judith Del Campo Ascarateil, Imene Turki Hani, Fergal Hill
  • Influenza nucleoprotein vaccines
    Patent number: 9243047
    Abstract: The present invention is related to a fusion protein comprising a variant of a nucleoprotein antigen from Influenza strain A, B or C, and a variant of a C4bp oligomerization domain for increasing the cellular immunogenicity of the nucleoprotein antigen from Influenza. The invention is also related to nucleic acids, vectors, fusion proteins and immunogenic compositions, for their use as a vaccine or immunotherapy for the prevention and treatment of influenza disease.
    Type: Grant
    Filed: December 15, 2014
    Date of Patent: January 26, 2016
    Assignee: Imaxio
    Inventors: Judith Del Campo Ascarateil, Fergal Hill
  • Influenza Nucleoprotein Vaccines
    Publication number: 20150098958
    Abstract: The present invention is related to a fusion protein comprising a variant of a nucleoprotein antigen from Influenza strain A, B or C, and a variant of a C4bp oligomerization domain for increasing the cellular immunogenicity of the nucleoprotein antigen from Influenza. The invention is also related to nucleic acids, vectors, fusion proteins and immunogenic compositions, for their use as a vaccine or immunotherapy for the prevention and treatment of influenza disease.
    Type: Application
    Filed: December 15, 2014
    Publication date: April 9, 2015
    Inventors: Judith DEL CAMPO ASCARATEIL, Fergal HILL
  • Modified Coiled Coil Type Proteins having Improved Properties
    Publication number: 20150093406
    Abstract: The present application is related to a modified protein comprising a protein having a coiled coil domain and a peptide having the sequence such as shown in SEQ ID NO 1: ZXBBBBZ that is linked to the coiled coil domain wherein: Z is any amino acid or is absent; X is any amino acid; B is an arginine (R) or a lysine (K). Said modified protein is in particular an antigen or a carrier protein, associated to an antigen. This modified protein has an increased affinity for negatively charged polymers such as nucleic acids or heparin, and shows an increased immunogenicity.
    Type: Application
    Filed: December 15, 2014
    Publication date: April 2, 2015
    Inventors: Judith DEL CAMPO ASCARATEIL, Imene TURKI HANI, Fergal HILL